About James Hussey
James Hussey is an executive vice chairman at InnovoTEX.
Form D filings also name James Hussey as CEO and director at Seneca Therapeutics.
James Hussey first appears on SEC filings in 2021.
Experience
This experience comes from James Hussey's profile and from SEC filings. For roles taken from filings, the years are when the filings name James Hussey in the role, so the role may have started earlier or lasted longer.
InnovoTEX Inc. Current
Executive Vice Chairman
Vice Chairman Capital Formation, Corporate Strategy, Clinical Development and Alliance Management (2026 – Present)
2026 – Present · Austin, TX
Develops cancer drugs designed to remain in tumors longer for people with cancer.
HC
Hussey Consulting Current
President
2026 – Present
RC
Research Instruments Corporation
Vice Chairman of the Board
2024 – 2026
JC
James Hussey Consulting
President
2019 – 2020
MA
MorphoSys AG
Special Advisor to the Chairman/Acting US President
2018 – 2019
AT
Athenex
Executive Vice President
2016 – 2018
SP
Sagent Pharmaceuticals
President
2013 – 2015
NI
NanoInk, Inc.
Chief Executive Officer
2008 – 2013
OP
Ovation Pharmaceuticals
VP Strategic Planning
2005 – 2008
NI
NeoPharm, Inc.
Chief Executive Officer
1998 – 2004
PC
Physicians Quality Care
Chief Executive Officer
1994 – 1998
BS
Bristol-Myers Squibb
General Manager
1984 – 1994
Key Colleagues at Startups
The people James Hussey works with at each company, as listed on that company's latest Form D.
InnovoTEX Inc. · Form D, Aug 18, 2026
JS
Jonathan Sessler
Director
Jonathan Arambula
Co-founder, CTO & Executive Chairman
Krystle Karoscik
Co-founder, CEO & Board Director
Seneca Therapeutics, Inc. · Form D, Feb 7, 2025
CD
Cuong Do
Executive officer and director
MK
Mark Kerschner
Director
PH
Paul Hallenbeck
Executive officer and director